Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Plos One|November 7, 2017
Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenariosDennis Kupitz, Christoph Wetz, Heiko Wissel, et al.
EJNMMI Research|March 23, 2023
Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectorsFelix Thiele, Franziska Schau, Julian M M Rogasch, et al.
Cancers|December 23, 2023
Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide TherapyChristoph Wetz, Tristan Ruhwedel, Imke Schatka, et al.
Plos One|January 7, 2014
High-field open versus short-bore magnetic resonance imaging of the spine: a randomized controlled comparison of image qualityJudith Enders, Matthias Rief, Elke Zimmermann, et al.
Molecular Imaging and Biology|October 16, 2016
Predictive Value of Asphericity in Pretherapeutic [<sup>111</sup>In]DTPA-Octreotide SPECT/CT for Response to Peptide Receptor Radionuclide Therapy with [<sup>177</sup>Lu]DOTATATEChristoph Wetz, I Apostolova, I G Steffen, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 7, 2022
Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosisFelix Kleefeld, Elise Scherret, Fabian Knebel, et al.
International Journal of Medical Informatics|January 23, 2026
Less time Coding, more time Caring: Performance evaluation of ChatGPT-5 for ICD-10 coding of radiology reportsTristan Ruhwedel, Julian M M Rogasch, Paul Martin Dahlke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 14, 2023
ChatGPT: Can You Prepare My Patients for [<sup>18</sup>F]FDG PET/CT and Explain My Reports?Julian M M Rogasch, Giulia Metzger, Martina Preisler, et al.
Plos One|May 16, 2019
The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATEChristoph Wetz, Philipp Genseke, Ivayla Apostolova, et al.
EJNMMI Research|August 28, 2025
AI-driven body composition monitoring and its prognostic role in mCRPC undergoing lutetium-177 PSMA radioligand therapy: insights from a retrospective single-center analysisTristan Ruhwedel, Julian Rogasch, Markus Galler, et al.
Pageof 3